WASHINGTON — Senate health committee Chair Bernie Sanders (I-Vt.) added three drug shortage measures to a pandemic-preparedness bill that his committee will consider Thursday. Only one of them, however, would grant the Food and Drug Administration new authorities to tackle the issue.
Congress is under pressure to stem drug shortages amid reports of doctors rationing chemotherapies and other essential medicines.
The new measure would require drug companies to tell the FDA the volume of ingredients they buy from each of their suppliers. Current law requires companies to disclose from whom they buy ingredients, but they don’t need to share how much of the ingredients they source from suppliers.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect